Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
SGMT	Sagimet Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$51.04M	n/a	-45.8%	n/a	-$1.58
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
JAGX	Jaguar Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.51M	-$53.58M	-465.4%	n/a	-1.5%	-$22.97
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
NXTC	NextCure, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.84M	n/a	-159.8%	n/a	-$19.65
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41
IMRX	Immuneering Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$56.02M	n/a	-25.6%	n/a	-$1.27
RLMD	Relmada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.39M	n/a	-66.3%	n/a	-$1.45
AARD	Aardvark Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$57.59M	n/a	-54.0%	n/a	-$2.93
BOLD	Boundless Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$58.20M	n/a	-59.0%	n/a	-$2.60
OKUR	OnKure Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.52M	n/a	-105.9%	n/a	-$4.40
CLYM	Climb Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.85M	n/a	-37.3%	n/a	-$0.88
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
NWBO	Northwest Biotherapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$1.38M	-$60.16M	n/m	n/a	-0.3%	-$0.04
HOWL	Werewolf Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$60.82M	n/a	-245.2%	n/a	-$1.33
ARDX	Ardelyx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$407.32M	-$61.60M	-15.1%	-36.9%	22.1%	-$0.26
BMEA	Biomea Fusion, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$61.80M	n/a	-209.1%	n/a	-$1.18
NTHI	Neonc Technologies Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.0K	-$62.15M	n/m	n/a	-51.8%	-$3.20
MIST	Milestone Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.06M	n/a	-151.0%	n/a	-$0.75
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ACRS	Aclaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.83M	-$64.92M	-829.6%	-63.0%	-58.2%	-$0.53
ARCT	Arcturus Therapeutics Holdings Inc. Manufacturing · Year ended 2025-12-31 · USD	$82.03M	-$65.78M	-80.2%	-30.7%	-46.1%	-$2.40
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22

Rows per page: 2550 100